The Aperlena Verdict
Open raceNo supplier dominates: 185 different companies have won the last 457 comparable contracts from this buyer over 5 years. This is a genuinely open race.
- 0%
- Expected final price vs the published estimate
Based on 457 comparable awards by this buyer in this sector over 5 years. Every verdict is recorded before the outcome and graded against the award notice. How we score ourselves.
Summary
Machine-generated summaryThe buyer is procuring human albumin for intravenous use, specifically the presentation 200 mg/ml in 50 ml solution for injection, intended to supply needs for 2017. The tender covers the supply of this single pharmaceutical product, a blood-derived medicine commonly used in hospitals to treat conditions such as hypovolaemia or hypoalbuminaemia. The contract concerns the acquisition and delivery of the medicinal product in this specified concentration and vial size, with no lots, quantities, deadlines, buyer names or further scope details given in the notice text. The procurement period referenced is the year 2017.
Official source
Source: BASE - Portal dos Contratos Públicos (IMPIC)
Always verify details on the official notice.
Last verified against BASE - Portal dos Contratos Públicos (IMPIC) 2 days ago
More from this buyer
Full buyer profile118 open tenders right now
- Purchase of ICU Beds No deadline published
- Purchase of Blood Collection Bags No deadline published
- Acquisition of an Echocardiograph No deadline published
Who usually wins this buyer's contracts in this sector
| Company | Wins | Total awarded | Last win |
|---|---|---|---|
| BRISTOL - MYERS SQUIBB SA. | 32 | €600,436 | Aug 2026 |
| MERCK SHARP & DOHME, LDA | 29 | €1.1M | Sep 2026 |
| ABBVIE, LDA | 13 | €286,211 | Sep 2026 |
| DAIICHI SANKYO PORTUGAL | 11 | €800,863 | Jul 2026 |
| AstraZeneca-Produtos Farmacêuticos, Lda | 9 | €384,195 | Aug 2026 |
Based on 457 awards with a linked company profile over the last 5 years.
What this buyer has paid before
Based on 459 comparable contracts this buyer awarded in this sector over the last 4 years.
- €3,170
- Lower quartile
- €12,362
- Median award
- €36,265
- Upper quartile
This tender is estimated 462.8% above that median
Most recent awards
- 11G0849126 Aquisição de matriz de colagénio para o Bloco de Cirúrgia Plástica Reconstrutiva da Unidade Local de Saúde de Amadora/Sintra, E.P.E. €5,800
- Aquisição de PEMBROLIZUMAB IV 25MG/ML 4 ML SOL INJ, ao Lab. Merck Sharp & Dohme, Para a ULSASI, Para o ano 2026 €39,600
- Aquisição de FIDAXOMICINA, ORAL, 200 MG, COMP ao abrigo do CPA 2026/5 para a ULSASI para o ano de 2026 €39,159
- Aquisição de DCI exclusiva por titularidade, UPADACITINIB ORAL 30MG COMP LP, para a ULSASI, para o ano 2026 €36,958
- Aquisição de FLURBIPROFENO, OFT, 0,3MGML, COLÍRIO ao abrigo do CPA 2024/782 para a ULSASI para o ano de 2026 €1,258
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
Similar tenders
1
day left
€47,991
est. value
2
days left
€318,040
est. value
2
days left
€445,890
est. value
2
days left
€604,860
est. value
Market context
- Avg. open tender · Medical equipment & pharmaceuticals
- €10,072,234
- Buyer track record on Aperlena
- 894 notices tracked · 515 awarded
- €115,603,603 in awarded contracts
Never miss a tender like this
1,155 new notices in Medical equipment & pharmaceuticals in Portugal in the last 7 days. Get an email when new ones appear. Free.
Set up my alert